BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10518973)

  • 1. [Pseudohypoparathyroidism and the concept of hormonal resistance. Types Ib and II].
    Vlaeminck-Guillem V; Wémeau JL
    Presse Med; 1999 Sep; 28(26):1442-7. PubMed ID: 10518973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudohypoparathyroidism and the concept of hormonal resistance. Types Ia and Ic and pseudohypoparathyroidism].
    Vlaeminck-Guillem V; Wémeau JL
    Presse Med; 1999 Sep; 28(26):1438-41. PubMed ID: 10518972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudohypoparathyroidism and the concept of hormonal resistance. Diagnosis, classification and therapy].
    Vlaeminck-Guillem V; Wémeau JL
    Presse Med; 1999 Sep; 28(26):1434-7. PubMed ID: 10518971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudohypoparathyroidism type Ia - a novel mutation].
    Reis Oliveira M; Oliveira Bandeira A; Rendeiro P; Silva Borges T; Cardoso H
    An Pediatr (Barc); 2010 Jun; 72(6):424-7. PubMed ID: 20409765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Albright hereditary osteodystrophy and related disorders.
    Koo BB; Schwindinger WF; Levine MA
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(1):3-13. PubMed ID: 7778442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The usefulness of the teriparatide acetate (Parathar) infusion test in the diagnosis of pseudohypoparathyroidism].
    Rius F; Salinas I; Reverter JL; Pizarro E; Lucas A
    Med Clin (Barc); 1993 Sep; 101(8):303-5. PubMed ID: 8397330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.
    Ish-Shalom S; Rao LG; Levine MA; Fraser D; Kooh SW; Josse RG; McBroom R; Wong MM; Murray TM
    J Bone Miner Res; 1996 Jan; 11(1):8-14. PubMed ID: 8770691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and epigenetics of parathyroid hormone resistance.
    Bastepe M
    Endocr Dev; 2013; 24():11-24. PubMed ID: 23392091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.
    Laspa E; Bastepe M; Jüppner H; Tsatsoulis A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5942-7. PubMed ID: 15579741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib.
    Mantovani G; Bondioni S; Linglart A; Maghnie M; Cisternino M; Corbetta S; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3738-42. PubMed ID: 17595244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?
    Mantovani G; Elli FM; Spada A
    Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudohypoparathyroidism type Ib in 2015.
    Mantovani G; Elli FM
    Ann Endocrinol (Paris); 2015 May; 76(2):101-4. PubMed ID: 25910998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudohypoparathyroidism.
    Johns Hopkins Med J; 1982 Sep; 151(3):137-46. PubMed ID: 6287085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of bone to parathyroid hormone in type I pseudohypoparathyroidism. 6 cases].
    Wemeau JL; Duquesnoy B; Grimbert I; Hubaud P; Hardouin P; Lemaitre G; Fossati P; Decoulx M
    Ann Med Interne (Paris); 1986; 137(3):220-5. PubMed ID: 3767189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohypoparathyroidism.
    Van Dop C; Bourne HR
    Annu Rev Med; 1983; 34():259-66. PubMed ID: 6344759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multihormonal resistance to parathyroid hormone, thyroid stimulating hormone, and other hormonal and neurosensory stimuli in patients with pseudohypoparathyroidism.
    Wémeau JL; Balavoine AS; Ladsous M; Velayoudom-Cephise FL; Vlaeminck-Guillem V
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():653-61. PubMed ID: 16789631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The resistance to parathyroid hormone of fibroblasts from some patients with type Ib pseudohypoparathyroidism is reversible with dexamethasone.
    Silve C; Suarez F; el Hessni A; Loiseau A; Graulet AM; Gueris J
    J Clin Endocrinol Metab; 1990 Sep; 71(3):631-8. PubMed ID: 2168431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidism type Ib.
    Fukumoto S; Suzawa M; Takeuchi Y; Kodama Y; Nakayama K; Ogata E; Matsumoto T; Fujita T
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2554-8. PubMed ID: 8675577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic defects at the GNAS locus cause different forms of pseudohypoparathyroidism.
    Jüppner H
    Ann Endocrinol (Paris); 2015 May; 76(2):92-7. PubMed ID: 25882888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.